Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data

BACKGROUND: Breast cancer (BC) is the leading cause of cancer death for Chilean women. About 11% of cases are triple-negative (TN) BC. These are characterised by poor prognosis, higher risk of early recurrence and visceral dissemination versus other BC subtypes. Current standard treatment for early-...

Descripción completa

Detalles Bibliográficos
Autores principales: Walbaum, Benjamín, Acevedo, Francisco, Medina, Lidia, Bravo, M Loreto, Merino, Tomas, Camus, Mauricio, Dominguez, Francisco, Mondaca, Sebastián, Galindo, Héctor, Nervi, Bruno, Ibañez, Carolina, Madrid, Jorge, Muñiz, Sabrina, Peña, José, Koch, Érica, Garrido, Marcelo, Pinto, Mauricio P, Sánchez, César
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987491/
https://www.ncbi.nlm.nih.gov/pubmed/33777171
http://dx.doi.org/10.3332/ecancer.2021.1178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987491/
https://www.ncbi.nlm.nih.gov/pubmed/33777171
http://dx.doi.org/10.3332/ecancer.2021.1178

Ejemplares similares